The strategies targeting the ghrelin-GHSR system for obesity and metabolic diseases include neutralization of ghrelin, antagonism of ghrelin receptor by its antagonists and inverse agonists, inhibition enzyme involved in ghrelin binding to GHSR, as well as a potential pharmacological target to decrease ghrelin secretion (108). This evidence concerns the gene GHRL and metabolic disease.